THC and Weightlifting: Does Cannabis Affect Muscle Growth or Recovery
Body / Physical
0 Studies
No study has ever directly measured THC's effect on muscle protein synthesis or strength gains, yet cannabis may undermine recovery by disrupting the REM sleep your body needs to repair and grow.
Kolodny et al. (1974)
Kolodny et al. (1974)
View as imageWalk into most commercial gyms and you will find a population that is deeply invested in optimizing every variable that might affect muscle growth. Protein timing, creatine supplementation, sleep hygiene, testosterone levels, cortisol management. The fitness community scrutinizes these factors obsessively. Cannabis, which interacts with several of these systems, occupies a strange position in this culture: widely used but rarely discussed honestly, and almost never with reference to actual evidence.
The question of whether THC affects muscle growth touches on hormones, sleep, inflammation, and neuromuscular function. The answer, as is common in cannabis research, is that we know less than people on either side of the argument tend to claim.
Key Takeaways
- THC may lower testosterone slightly in the short term, but the dip appears small and temporary — unlikely to meaningfully hurt muscle growth for most people based on available evidence
- Cannabis disrupts REM sleep, and sleep quality is one of the biggest factors in muscle recovery and growth hormone release, so even sleeping the same number of hours may not give you the same repair
- No study has ever directly measured whether THC affects muscle protein synthesis, hypertrophy, or strength gains over a training cycle, so confident claims in either direction are premature
- THC's anti-inflammatory effects sound helpful for recovery, but your body needs post-workout inflammation to adapt and grow stronger — so suppressing it might actually blunt your training response
- Lifting heavy while high is a real safety concern because THC impairs coordination, and a missed groove on a squat or bench press can cause serious injury
- You cannot trust your own assessment of how well you trained while high because THC warps self-evaluation — many lifters who quit are shocked at the gap between what they thought they accomplished and what they actually did
Testosterone: The Primary Concern
THC & Lifting: What We Know (and Don't) About Gains
Testosterone is the hormone most directly associated with muscle growth, and it is the variable that fitness-oriented cannabis users worry about most. The concern has some basis. Early animal studies from the 1970s and 1980s showed that high-dose THC administration could suppress testosterone levels in rodents. Some early human studies, notably by Kolodny and colleagues (1974), reported lower testosterone levels in chronic heavy cannabis users compared to non-users.
However, subsequent research has complicated this picture considerably. A 1991 review by Block and colleagues concluded that the testosterone-suppressive effects of cannabis in humans are small, inconsistent, and most likely reversible with cessation. Several larger epidemiological studies have failed to find clinically significant differences in testosterone levels between cannabis users and non-users.
The most balanced reading of the evidence is that THC may produce a modest, transient suppression of testosterone, particularly with acute high-dose use, but the magnitude of this effect is unlikely to produce measurable differences in muscle growth for most users. Testosterone must drop substantially and persistently to meaningfully impair hypertrophy. The fluctuations associated with cannabis use appear to be within the range of normal daily variation.
That said, users taking exogenous testosterone or other hormones should be aware that cannabinoid interactions with the hypothalamic-pituitary-gonadal axis are not fully characterized. If you are already manipulating your hormonal environment, adding another variable that touches the same system introduces unpredictable complexity.
Cortisol and Stress Hormones
Cortisol is catabolic, meaning it breaks down tissue, and elevated cortisol is associated with impaired muscle recovery and growth. Chronic stress, sleep deprivation, and overtraining all elevate cortisol. Some cannabis users report that THC helps them relax and reduce stress, which could theoretically lower cortisol.
The evidence on THC and cortisol is mixed. Acute THC administration can transiently increase cortisol levels, possibly through activation of the hypothalamic-pituitary-adrenal (HPA) axis. However, chronic users often show blunted cortisol responses, suggesting adaptation. Whether this blunted response is beneficial (less catabolic signaling) or problematic (disrupted stress response) is unclear.
In practical terms, if cannabis helps a lifter sleep better, reduce anxiety, and recover from training stress, those downstream effects may be more important than any direct cortisol interaction. But if cannabis is disrupting sleep quality (see below), the net effect on the cortisol picture may be negative.
Growth Hormone
Growth hormone (GH) is released in pulses during deep sleep and contributes to tissue repair and growth. One early study suggested that THC might suppress GH release, but the evidence base is thin and the clinical significance of any such effect is uncertain. GH's role in muscle hypertrophy in healthy adults with normal hormone levels is often overstated in fitness culture. The primary driver of muscle growth is mechanical tension applied through progressive overload, not hormonal optimization within normal ranges.
The GH concern is theoretically valid but practically minor compared to the sleep quality issue it connects to.
Sleep: The Underappreciated Variable
Sleep is arguably the most important recovery variable for muscle growth. During deep sleep, growth hormone is released, protein synthesis is elevated, and damaged tissue is repaired. Sleep deprivation has been consistently shown to impair strength, reduce testosterone, elevate cortisol, and diminish training adaptation.
THC's effect on sleep is complex and directly relevant. Cannabis users commonly report that THC helps them fall asleep faster, and this is supported by some evidence. However, THC reliably suppresses REM sleep, reduces sleep spindle activity, and alters sleep architecture in ways that may compromise the restorative quality of sleep even when total sleep duration is maintained.
For a lifter who trains intensely and relies on sleep for recovery, the question is whether falling asleep faster compensates for reduced sleep quality. The answer depends on the individual's baseline. Someone with severe insomnia who would otherwise lie awake for hours might gain net recovery benefit from THC-assisted sleep despite REM suppression. Someone who sleeps well without cannabis and adds THC to the equation is likely degrading the recovery quality of their sleep.
Chronic REM suppression also has cognitive consequences that may affect training. Memory consolidation, motor skill learning, and emotional regulation all depend on REM sleep. For lifters working on technical skills, learning new movements, or managing the psychological stress of hard training, REM suppression is not trivial.
Protein Synthesis: The Missing Data
Here is where the evidence gets embarrassingly thin. No published, peer-reviewed study has directly measured the effect of THC on muscle protein synthesis (MPS) in humans. MPS is the cellular process that builds new muscle tissue in response to resistance training. It is the fundamental mechanism of hypertrophy.
We can speculate based on indirect evidence. THC interacts with mTOR signaling pathways (a key regulator of protein synthesis) in some cell types, but the relevance of these in vitro findings to skeletal muscle in a human lifter consuming oral or inhaled THC is unknown. CB1 receptors are present in skeletal muscle, but their functional role in the muscle growth response to resistance training has not been characterized.
The absence of evidence is not evidence of absence. THC might impair MPS, enhance it, or have no meaningful effect. We genuinely do not know. Anyone claiming that cannabis definitely helps or definitely hurts muscle growth is stating a conclusion the evidence does not support.
Anti-Inflammatory Effects: A Double-Edged Sword
Both THC and CBD have anti-inflammatory properties, and the fitness community has embraced this as a recovery benefit. The reasoning seems straightforward: intense training causes inflammation, inflammation causes soreness and delayed recovery, cannabinoids reduce inflammation, therefore cannabinoids aid recovery.
The problem with this reasoning is that acute post-exercise inflammation is not pathological. It is part of the adaptive response. The inflammatory cascade that follows resistance training activates satellite cells, promotes tissue remodeling, and signals the body to build stronger structures. This is why chronic NSAID use after training is discouraged by many exercise scientists. Suppressing the inflammatory signal may suppress the adaptation.
The same logic applies to cannabinoids. If THC and CBD are meaningfully anti-inflammatory at the doses consumed by recreational users (which is itself debatable), and if they suppress the post-exercise inflammatory response, they could theoretically blunt the training adaptation they are intended to support.
This remains theoretical. No study has measured whether cannabis users show attenuated hypertrophy or strength gains over a training cycle compared to matched non-users. The theoretical concern exists, but the practical magnitude is unknown.
Coordination, Safety, and the Gym
The safety concern with THC and weightlifting is straightforward and well-supported. THC impairs coordination, proprioception, and reaction time. Compound barbell movements like squats, deadlifts, and overhead presses require precise motor control and the ability to react quickly if the lift deviates from the intended path.
A failed squat under heavy load is dangerous sober. With impaired coordination and reduced proprioception, the risk of a catastrophic failure increases. This is not a marginal concern for serious lifters working at high percentages of their one-rep maximum.
Machine-based exercises and bodyweight movements carry less risk in this regard, but any exercise involving free weights and heavy loads demands full neuromuscular control. Being honest about this does not require moralizing. It requires acknowledging that barbells do not care about your intentions, and impaired motor control in a high-force environment is how injuries happen.
What Bodybuilders and Lifters Report
Anecdotally, cannabis-using lifters report a range of experiences. Some describe improved mind-muscle connection at low doses, claiming they can feel the target muscle working more intensely. Others report that cannabis helps them tolerate the discomfort of high-volume training. Some say it helps with appetite, which is relevant for lifters in a caloric surplus trying to gain weight.
On the other side, some report reduced motivation to train, lower workout intensity, and a tendency to skip sessions on days when they use cannabis. The motivational effects are highly individual and likely dose-dependent.
These reports are difficult to evaluate because they are colored by expectations, dose variability, tolerance differences, and the absence of objective performance tracking in most cases. A lifter who believes cannabis helps their workout will interpret the experience through that lens.
An Honest Assessment for Lifters
The evidence does not support the claim that cannabis meaningfully impairs muscle growth in most users. Nor does it support the claim that cannabis enhances muscle growth or recovery. The honest answer is that the direct research essentially does not exist.
What we can say is that the indirect pathways through which THC might affect muscle growth (testosterone, cortisol, sleep, inflammation) are mostly modest in magnitude and complex in direction. The most likely significant impact is on sleep quality, which is both well-documented and directly relevant to recovery.
For lifters who choose to use cannabis, the practical considerations are: avoid using before training with heavy free weights, be attentive to sleep quality rather than just sleep quantity, do not assume anti-inflammatory effects are beneficial for training adaptation, and track your actual performance data over time rather than relying on subjective impressions of how your training feels.
The fitness community wants a clear answer. Cannabis either builds muscle or kills gains. The evidence provides neither conclusion. What it provides is a collection of modest, indirect effects that are unlikely to be the determining factor in any lifter's progress. Training intensity, progressive overload, adequate protein, and sleep quality matter far more than whether you use cannabis. Getting those right while using cannabis moderately is almost certainly fine. Getting those wrong while not using cannabis will stall your progress regardless.
The Bottom Line
Evidence review of THC and muscle growth covering testosterone, cortisol, sleep, protein synthesis, inflammation, and gym safety. Testosterone: Kolodny 1974 — early studies showed suppression in heavy users; Block 1991 review — effects small, inconsistent, reversible; larger epidemiological studies found no clinically significant differences; likely modest transient suppression within normal daily variation, unlikely to impair hypertrophy. Cortisol: acute THC may transiently increase cortisol (HPA axis activation); chronic users show blunted cortisol responses; net effect unclear. Growth hormone: one early study suggested suppression but evidence thin; GH role in hypertrophy in healthy adults overstated. Sleep: THC helps fall asleep faster but suppresses REM, reduces sleep spindles, alters architecture; sleep is most important recovery variable; net benefit depends on baseline (insomniac may gain, good sleeper may lose quality). Protein synthesis: NO published study has directly measured THC effect on MPS in humans; CB1 present in skeletal muscle but functional role in hypertrophy uncharacterized; confident claims premature. Anti-inflammatory: THC/CBD anti-inflammatory properties documented but acute post-exercise inflammation necessary for adaptation (satellite cells, tissue remodeling); chronic suppression may blunt training response (same concern as chronic NSAID use). Safety: THC impairs coordination/proprioception; compound barbell lifts (squat, deadlift, overhead press) under heavy load + impaired motor control = serious injury risk. Bottom line: indirect pathways modest in magnitude; sleep quality most significant; no evidence cannabis meaningfully impairs or enhances muscle growth; training intensity, overload, protein, and sleep matter far more.
Frequently Asked Questions
Sources & References
- 1RTHC-07926·Ware, Orrin D (2025). “Cannabis Use Disorder Cases in U.S. Mental Health Treatment Nearly Doubled From 2013 to 2018.” Substance use : research and treatment.Study breakdown →PubMed →↩
- 2RTHC-07707·Spiga, Francesca et al. (2025). “Is There a Pill to Help You Quit Cannabis? The Cochrane Review Says Not Yet.” The Cochrane database of systematic reviews.Study breakdown →PubMed →↩
- 3RTHC-00218·Budney, Alan J. et al. (2006). “Paying for Clean Tests Worked During Treatment. Therapy Helped It Last..” Journal of Consulting and Clinical Psychology.Study breakdown →PubMed →↩
- 4RTHC-00166·Haney, Margaret et al. (2004). “Can Oral THC Pills Ease Marijuana Withdrawal? A Controlled Study Says Yes.” Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.Study breakdown →PubMed →↩
- 5RTHC-08112·Bedillion, Margaret F et al. (2026). “Why There's Still No FDA-Approved Medication for Cannabis Addiction.” Current topics in behavioral neurosciences.Study breakdown →PubMed →↩
- 6RTHC-00188·González, Sara et al. (2005). “Comprehensive Review of Cannabis Tolerance and Dependence in Laboratory Animals.” Pharmacology.Study breakdown →PubMed →↩
- 7RTHC-00203·Raphael, Beverley et al. (2005). “Review of Cannabis Health Risks: Psychosis Link Strong, Withdrawal Syndrome Real, Gateway Theory Debated.” Journal of psychiatric practice.Study breakdown →PubMed →↩
- 8RTHC-00159·Budney, Alan J. et al. (2004). “Yes, Cannabis Withdrawal Is Real. This 2004 Review Mapped What It Looks Like..” American Journal of Psychiatry.Study breakdown →PubMed →↩
Research Behind This Article
Showing the 8 most relevant studies from our research database.
Alcohol and Cannabis Use Disorder Diagnoses in Mental Health Treatment 2013 to 2022: A Descriptive Epidemiological Study.
Ware, Orrin D · 2025
Of 3.95 million cases with alcohol or cannabis use disorder in mental health treatment, 1.63 million had CUD.
Pharmacotherapies for cannabis use disorder.
Spiga, Francesca · 2025
This is the gold standard of evidence synthesis: a Cochrane systematic review, now in its second update since 2014.
Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence
Budney, Alan J. · 2006
Three groups were compared for 14 weeks: cognitive-behavioral therapy (CBT) alone, abstinence-based voucher incentives alone, and the combination.
Marijuana withdrawal in humans: effects of oral THC or divalproex.
Haney, Margaret · 2004
In two controlled studies with heavy marijuana users (6-10 joints per day), oral THC (10 mg five times daily) administered during marijuana abstinence decreased anxiety, misery, trouble sleeping, chills, and craving, and reversed large decreases in food intake.
Association of Physical Activity, Sedentary Behavior, and Cannabis Use: A Cross-Sectional Study.
Dai, Jinming · 2026
After adjusting for covariates, sedentary behavior was positively associated with cannabis use (OR=1.365), as were work physical activity (OR=1.135) and commuting activity (OR=1.209).
The impact of cannabis co-use and cannabis use disorder on interest in and barriers to tobacco cessation.
Graham, Francis Julian L · 2026
Adults with CUD had the highest total barriers to smoking cessation (score 20.3 vs.
Consumption patterns and withdrawal symptoms in dual cannabis-tobacco users in Spain: Cross-sectional study.
Saura, Judith · 2026
This cross-sectional study of 94 participants entering cannabis use disorder treatment in Catalonia, Spain, documented the deeply intertwined nature of cannabis and tobacco use in a European context where mixing the two substances in "spliffs" is the dominant consumption method. Daily tobacco use was reported by 91.5% of participants, with a mean Fagerström nicotine dependence score of 4.2 out of 10 (moderate dependence).
Understanding Tobacco and Cannabis Co-Use, Cessation Strategies and Intervention Opportunities with Young Adults in UK Further Education Colleges: A Mixed Methods Study.
Walsh, Hannah · 2025
86.5% had made some effort to quit or reduce tobacco and/or cannabis in the past 6 months, but few used formal support.